Cansino Historical Balance Sheet

688185 Stock

55.11 1.99 3.49%

Trend analysis of Cansino Biologics balance sheet accounts such as Other Current Liab of 769.2 M, Total Current Liabilities of 3.1 B or Total Stockholder Equity of 4.5 B provides information on Cansino Biologics' total assets, liabilities, and equity, which is the actual value of Cansino Biologics to its prevalent stockholders. By breaking down trends over time using Cansino Biologics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Cansino Biologics Inventory

330.16 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Cansino Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cansino Biologics at a specified time, usually calculated after every quarter, six months, or one year. Cansino Biologics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cansino Biologics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cansino currently owns. An asset can also be divided into two categories, current and non-current.

Cansino Biologics Balance Sheet Chart

At present, Cansino Biologics' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 3.1 B, whereas Total Assets are forecasted to decline to about 6.7 B.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of Cansino Biologics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cansino Biologics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cansino Biologics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cansino Biologics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Cansino Biologics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cansino Biologics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2024	2025 (projected)
Other Current Liabilities	637.0M	732.5M	769.2M
Total Assets	11.5B	10.7B	6.7B

Other Current Liab Total Assets

Cansino Biologics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets
Total Assets		0.89	0.92	0.98	0.98	0.99	0.85	-0.22	0.72	0.89	0.86	0.86	0.82	0.66	0.79	0.88	0.96	0.77	0.94	0.92	-0.69	0.89	0.7	1.0	0.88	0.98
Other Current Liab	0.89		0.99	0.82	0.87	0.84	0.8	-0.44	0.57	0.67	0.98	0.79	0.95	0.89	0.94	0.89	0.92	0.95	0.81	0.81	-0.61	1.0	0.67	0.88	1.0	0.82
Total Current Liabilities	0.92	0.99		0.86	0.88	0.87	0.82	-0.33	0.67	0.74	0.96	0.81	0.92	0.83	0.91	0.87	0.95	0.91	0.88	0.87	-0.63	0.99	0.65	0.91	0.99	0.88
Total Stockholder Equity	0.98	0.82	0.86		0.96	0.99	0.87	-0.19	0.74	0.96	0.8	0.88	0.76	0.56	0.7	0.85	0.9	0.68	0.92	0.9	-0.71	0.82	0.67	0.98	0.8	0.99
Other Liab	0.98	0.87	0.88	0.96		0.99	0.86	-0.38	0.58	0.84	0.87	0.87	0.85	0.71	0.8	0.91	0.94	0.8	0.85	0.86	-0.7	0.87	0.78	0.99	0.86	0.94
Net Tangible Assets	0.99	0.84	0.87	0.99	0.99		0.87	-0.28	0.68	0.92	0.83	0.88	0.8	0.62	0.73	0.89	0.92	0.73	0.89	0.89	-0.71	0.84	0.72	0.99	0.83	0.97
Net Debt	0.85	0.8	0.82	0.87	0.86	0.87		-0.45	0.52	0.78	0.86	1.0	0.85	0.69	0.74	0.86	0.79	0.77	0.73	0.74	-0.79	0.82	0.86	0.87	0.8	0.83
Retained Earnings	-0.22	-0.44	-0.33	-0.19	-0.38	-0.28	-0.45		0.39	-0.02	-0.57	-0.44	-0.65	-0.74	-0.55	-0.54	-0.21	-0.66	0.09	-0.05	0.29	-0.44	-0.64	-0.27	-0.43	-0.09
Accounts Payable	0.72	0.57	0.67	0.74	0.58	0.68	0.52	0.39		0.79	0.46	0.52	0.34	0.14	0.32	0.46	0.68	0.3	0.89	0.84	-0.43	0.56	0.14	0.68	0.55	0.8
Cash	0.89	0.67	0.74	0.96	0.84	0.92	0.78	-0.02	0.79		0.64	0.79	0.6	0.36	0.51	0.73	0.76	0.5	0.88	0.84	-0.64	0.68	0.5	0.9	0.65	0.96
Non Current Assets Total	0.86	0.98	0.96	0.8	0.87	0.83	0.86	-0.57	0.46	0.64		0.85	0.99	0.94	0.95	0.91	0.87	0.98	0.74	0.76	-0.64	0.99	0.77	0.86	0.98	0.78
Non Currrent Assets Other	0.86	0.79	0.81	0.88	0.87	0.88	1.0	-0.44	0.52	0.79	0.85		0.84	0.68	0.73	0.86	0.79	0.76	0.73	0.74	-0.78	0.81	0.87	0.87	0.79	0.83
Other Assets	0.82	0.95	0.92	0.76	0.85	0.8	0.85	-0.65	0.34	0.6	0.99	0.84		0.96	0.97	0.9	0.83	0.99	0.67	0.68	-0.62	0.96	0.82	0.84	0.96	0.74
Long Term Debt	0.66	0.89	0.83	0.56	0.71	0.62	0.69	-0.74	0.14	0.36	0.94	0.68	0.96		0.96	0.81	0.71	0.99	0.49	0.52	-0.49	0.89	0.74	0.67	0.9	0.54
Net Receivables	0.79	0.94	0.91	0.7	0.8	0.73	0.74	-0.55	0.32	0.51	0.95	0.73	0.97	0.96		0.82	0.84	0.98	0.67	0.64	-0.55	0.95	0.74	0.79	0.96	0.7
Common Stock Shares Outstanding	0.88	0.89	0.87	0.85	0.91	0.89	0.86	-0.54	0.46	0.73	0.91	0.86	0.9	0.81	0.82		0.83	0.87	0.71	0.77	-0.66	0.89	0.77	0.89	0.87	0.82
Short Term Investments	0.96	0.92	0.95	0.9	0.94	0.92	0.79	-0.21	0.68	0.76	0.87	0.79	0.83	0.71	0.84	0.83		0.81	0.92	0.88	-0.67	0.92	0.67	0.95	0.92	0.92
Non Current Liabilities Total	0.77	0.95	0.91	0.68	0.8	0.73	0.77	-0.66	0.3	0.5	0.98	0.76	0.99	0.99	0.98	0.87	0.81		0.62	0.64	-0.56	0.96	0.75	0.77	0.96	0.67
Inventory	0.94	0.81	0.88	0.92	0.85	0.89	0.73	0.09	0.89	0.88	0.74	0.73	0.67	0.49	0.67	0.71	0.92	0.62		0.93	-0.59	0.82	0.48	0.92	0.81	0.96
Other Current Assets	0.92	0.81	0.87	0.9	0.86	0.89	0.74	-0.05	0.84	0.84	0.76	0.74	0.68	0.52	0.64	0.77	0.88	0.64	0.93		-0.44	0.81	0.54	0.9	0.8	0.92
Other Stockholder Equity	-0.69	-0.61	-0.63	-0.71	-0.7	-0.71	-0.79	0.29	-0.43	-0.64	-0.64	-0.78	-0.62	-0.49	-0.55	-0.66	-0.67	-0.56	-0.59	-0.44		-0.62	-0.58	-0.7	-0.61	-0.68
Total Liab	0.89	1.0	0.99	0.82	0.87	0.84	0.82	-0.44	0.56	0.68	0.99	0.81	0.96	0.89	0.95	0.89	0.92	0.96	0.82	0.81	-0.62		0.7	0.89	1.0	0.83
Deferred Long Term Liab	0.7	0.67	0.65	0.67	0.78	0.72	0.86	-0.64	0.14	0.5	0.77	0.87	0.82	0.74	0.74	0.77	0.67	0.75	0.48	0.54	-0.58	0.7		0.73	0.69	0.6
Net Invested Capital	1.0	0.88	0.91	0.98	0.99	0.99	0.87	-0.27	0.68	0.9	0.86	0.87	0.84	0.67	0.79	0.89	0.95	0.77	0.92	0.9	-0.7	0.89	0.73		0.87	0.98
Short Long Term Debt	0.88	1.0	0.99	0.8	0.86	0.83	0.8	-0.43	0.55	0.65	0.98	0.79	0.96	0.9	0.96	0.87	0.92	0.96	0.81	0.8	-0.61	1.0	0.69	0.87		0.81
Total Current Assets	0.98	0.82	0.88	0.99	0.94	0.97	0.83	-0.09	0.8	0.96	0.78	0.83	0.74	0.54	0.7	0.82	0.92	0.67	0.96	0.92	-0.68	0.83	0.6	0.98	0.81

Click cells to compare fundamentals

Cansino Biologics Account Relationship Matchups

Cansino Biologics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	6.7B	11.9B	11.5B	9.3B	10.7B	6.7B
Other Current Liab	57.7M	142.3M	544.4M	637.0M	732.5M	769.2M
Total Current Liabilities	409.5M	2.9B	2.9B	2.6B	3.0B	3.1B
Total Stockholder Equity	6.1B	8.0B	6.7B	5.3B	6.1B	4.5B
Other Liab	59.8M	174.0M	202.0M	222.4M	255.7M	134.3M
Net Tangible Assets	1.5B	6.0B	7.8B	6.5B	7.5B	4.2B
Retained Earnings	(764.7M)	1.1B	42.7M	(1.6B)	(1.4B)	(1.3B)
Accounts Payable	60.6M	842.6M	253.1M	104.0M	119.6M	200.3M
Cash	4.4B	5.5B	3.4B	2.0B	2.4B	2.5B
Non Current Assets Total	1.3B	2.6B	3.7B	4.1B	4.8B	5.0B
Other Assets	88.7M	151.1M	148.6M	398.7M	458.5M	481.5M
Long Term Debt	90M	40M	878.0M	1.1B	1.2B	1.3B
Net Receivables	21.6M	157.9M	855.5M	636.9M	732.4M	769.0M
Short Term Investments	666.6M	2.3B	2.6B	2.1B	2.4B	1.4B
Non Current Liabilities Total	264.4M	451.4M	1.3B	1.4B	1.7B	1.7B
Inventory	170.5M	875.6M	677.8M	350.7M	403.3M	330.2M
Other Current Assets	23.1M	114.1M	454.5M	245.0M	281.8M	181.3M
Total Liab	677.2M	3.3B	4.2B	4.0B	4.6B	4.9B
Deferred Long Term Liab	52.2M	43.4M	26.2M	52.0M	59.7M	41.5M
Net Invested Capital	6.2B	9.1B	9.2B	7.7B	8.9B	5.5B
Short Long Term Debt	40.2M	1.1B	1.6B	1.4B	1.6B	1.7B
Total Current Assets	5.4B	9.3B	7.7B	5.2B	6.0B	4.6B
Net Working Capital	5.0B	6.4B	4.8B	2.6B	3.0B	3.1B
Intangible Assets	72.3M	198.3M	258.7M	205.6M	236.5M	138.9M
Property Plant Equipment	574.9M	873.9M	2.2B	3.1B	3.5B	3.7B
Property Plant And Equipment Net	881.9M	2.2B	3.1B	3.0B	3.5B	2.2B
Capital Lease Obligations	12.4M	254.0M	247.0M	239.8M	275.8M	169.4M
Property Plant And Equipment Gross	967.3M	2.3B	3.4B	3.9B	4.5B	2.5B

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

Other Information on Investing in Cansino Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cansino Historical Balance Sheet

Cansino Biologics Inventory

330.16 Million

About Cansino Balance Sheet Analysis

Cansino Biologics Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Cansino Biologics balance sheet Correlations

Cansino Biologics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cansino Biologics balance sheet Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Assets
Total Liab	+ 1.0	Other Current Liab
Short Long Term Debt	+ 1.0	Other Current Liab
Non Currrent Assets Other	+ 1.0	Net Debt
Short Long Term Debt	+ 1.0	Total Liab
Net Tangible Assets	+ 0.99	Total Assets

Other Stockholder Equity	- 0.79	Net Debt
Other Stockholder Equity	- 0.78	Non Currrent Assets Other
Long Term Debt	- 0.74	Retained Earnings
Other Stockholder Equity	- 0.71	Net Tangible Assets
Other Stockholder Equity	- 0.71	Total Stockholder Equity
Net Invested Capital	- 0.7	Other Stockholder Equity